天新药业
(603235)
| 流通市值：39.66亿 | | | 总市值：118.07亿 |
| 流通股本：1.47亿 | | | 总股本：4.38亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,624,868,496.05 | 1,961,137,890.65 | 2,379,812,588.34 | 2,307,830,751.93 |
| 应收票据及应收账款 | 313,814,615.58 | 336,308,529.81 | 323,815,947.54 | 281,051,321.82 |
| 其中：应收票据 | 89,189,854.77 | 58,683,356.41 | 58,807,037.57 | 53,292,563.09 |
| 应收账款 | 224,624,760.81 | 277,625,173.4 | 265,008,909.97 | 227,758,758.73 |
| 应收款项融资 | 54,874,253.04 | 12,962,264.32 | 27,406,483.28 | 3,292,184.01 |
| 预付款项 | 47,500,415.92 | 27,141,951.21 | 45,005,934.29 | 22,056,580.75 |
| 其他应收款合计 | 2,074,833.93 | 2,062,131.88 | 2,294,957.87 | 1,702,193.2 |
| 存货 | 494,189,096.29 | 475,288,977.83 | 434,430,379.01 | 478,965,233.63 |
| 其他流动资产 | 50,436,460.4 | 38,202,841.58 | 23,817,411.68 | 26,413,558.21 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,707,758,171.21 | 2,853,104,587.28 | 3,236,583,702.01 | 3,121,311,823.55 |
| 非流动资产: | | | | |
| 长期股权投资 | 25,145.26 | 25,145.26 | 25,145.26 | 25,145.26 |
| 固定资产 | 1,214,407,845.09 | 1,196,626,984.89 | 1,219,821,427.73 | 1,175,371,801.24 |
| 在建工程 | 960,286,756.38 | 638,541,857.7 | 408,105,078.79 | 435,368,164.72 |
| 使用权资产 | 5,427,278.57 | 6,152,978.59 | 6,878,678.62 | 7,604,378.64 |
| 无形资产 | 189,566,351.02 | 190,426,444.96 | 191,454,527.43 | 192,311,293.45 |
| 长期待摊费用 | 9,953,813.75 | 10,300,273.01 | 10,646,732.27 | 10,993,191.53 |
| 递延所得税资产 | 78,991,373.78 | 80,960,191.94 | 80,195,647.31 | 81,125,270.93 |
| 其他非流动资产 | 105,951,364.9 | 126,506,685.2 | 95,900,236.27 | 66,048,109.02 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,564,609,928.75 | 2,249,540,561.55 | 2,013,027,473.68 | 1,968,847,354.79 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,272,368,099.96 | 5,102,645,148.83 | 5,249,611,175.69 | 5,090,159,178.34 |
| 流动负债: | | | | |
| 短期借款 | 1,000,666.67 | 20,013,333.33 | 220,014,666.67 | 100,072,222.22 |
| 应付票据及应付账款 | 166,510,248.17 | 129,708,878.15 | 117,858,302.37 | 138,069,304.85 |
| 其中：应付票据 | - | 13,150,000 | 26,480,000 | 11,430,000 |
| 应付账款 | 166,510,248.17 | 116,558,878.15 | 91,378,302.37 | 126,639,304.85 |
| 合同负债 | 21,048,141.89 | 19,874,071.54 | 23,145,159.28 | 21,098,771.55 |
| 应付职工薪酬 | 77,895,628.12 | 57,889,037.97 | 37,076,237.97 | 104,987,763.19 |
| 应交税费 | 23,590,021.83 | 54,165,128.08 | 43,851,113.97 | 33,890,925.82 |
| 其他应付款合计 | 6,019,733.09 | 6,893,166.78 | 19,540,826.18 | 8,578,504.58 |
| 一年内到期的非流动负债 | 2,902,800.12 | 2,902,800.11 | 2,976,222.84 | 3,123,735.24 |
| 其他流动负债 | 47,251,505.09 | 41,805,596.56 | 44,425,035.58 | 51,506,813.5 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 346,218,744.98 | 333,252,012.52 | 508,887,564.86 | 461,328,040.95 |
| 非流动负债: | | | | |
| 长期借款 | 100,033,981.82 | 65,228,227 | - | - |
| 租赁负债 | 2,994,028.39 | 3,779,269.59 | 4,482,375.85 | 5,095,912.47 |
| 递延收益 | 366,459,535.04 | 372,569,044.52 | 381,678,554 | 390,788,063.48 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 469,487,545.25 | 441,576,541.11 | 386,160,929.85 | 395,883,975.95 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 815,706,290.23 | 774,828,553.63 | 895,048,494.71 | 857,212,016.9 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 437,780,000 | 437,780,000 | 437,780,000 | 437,780,000 |
| 资本公积 | 1,994,353,349.28 | 1,991,869,343.51 | 1,989,385,337.74 | 1,986,901,331.97 |
| 减:库存股 | 60,014,480.99 | 37,061,173.22 | 28,417,490.56 | - |
| 盈余公积 | 218,890,000 | 218,890,000 | 218,890,000 | 218,890,000 |
| 未分配利润 | 1,865,652,941.44 | 1,716,338,424.91 | 1,736,924,833.8 | 1,589,375,829.47 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,456,661,809.73 | 4,327,816,595.2 | 4,354,562,680.98 | 4,232,947,161.44 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,456,661,809.73 | 4,327,816,595.2 | 4,354,562,680.98 | 4,232,947,161.44 |
| 负债和股东权益合计 | 5,272,368,099.96 | 5,102,645,148.83 | 5,249,611,175.69 | 5,090,159,178.34 |
| 公告日期 | 2024-10-30 | 2024-08-31 | 2024-04-30 | 2024-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |